AmpliMed's Series B - II Round

AmpliMed raised a round of funding on November 21, 2006.

AmpliMed Corporation, a clinical-stage pharmaceutical company founded by oncologists is focused on a lead compound, Amplimexon, which per AmpliMed has shown early evidence of efficacy and low levels o…

Articles about AmpliMed's Series B - II Round: